# FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT

> **NCT01132495** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1170 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **OTHER:** Stenting plus OMT
- **OTHER:** OMT
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT01132495
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-01
- **Final completion:** 2015-05
- **Target enrollment:** 1170 (ACTUAL)
- **Last updated:** 2019-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132495, "FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01132495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*